Literature DB >> 28674834

Intraocular silicone implant to treat chronic ocular hypotony: an in vivo trial.

Wesal Bayoudh1,2, Dörthe Carstesen3, Peter Walter3, Andreas W A Weinberger3,4,5.   

Abstract

PURPOSE: The management of chronic ocular hypotony and complicated proliferative vitreoretinopathy-related retinal detachment represents a challenge. Being non-absorbable and non-biodegradable, a silicone oil implant is expected to restore the volume and the intraocular pressure of the globe, as well as to approximate the detached retina. Further advantages could be a long-term tamponade potential, absence of toxicity, and prevention of silicone oil emulsification or anterior chamber oil-prolapse. The aim of this study was to assess the histological tolerance of the silicone oil implant in a pig model.
METHODS: A seamless silicone balloon implant with optional surface modifications was developed. Mini pigs were used as experimental animals, and three variants of silicone implants with different surfaces were tested: uncoated, NCO-sP(EO-stat-PO) coated, and heparin-NCO-sP(EO-stat-PO) coated silicone implants. An extracapsular lens extraction was achieved via a standard phacoemulsification followed by a standard three-port vitrectomy. The implant was then placed in the posterior segment and filled with 5000 centistoke silicone oil. One month later, the pigs were euthanized, the eyes were enucleated, and histological specimens were prepared for microscopy.
RESULTS: The analysis of the histology revealed that adverse histological changes in conjunctiva, cornea, iris, and ciliary body could be excluded in all eyes operated on regardless of which variant of implant had been employed. The retina as the implant-contacting ocular tissue showed overall good tolerance, although some inflammatory reaction and fibrous proliferation was evident in some cases.
CONCLUSIONS: The silicone oil implant is a promising candidate and has the potential to fulfill clinical requirements to act as a long-term intraocular tamponade agent. The heparin-NCO-sP(EO-stat-PO) coating approach could lead to a novel bioactive surface for intraocular devices with excellent properties to hinder cell adhesion and protein adsorption, although further studies will be necessary to evaluate long-term biocompatibility and long-term resistance to biological attacks.

Entities:  

Keywords:  Histological tolerance; Ocular hypotony; Proliferative vitreoretinopathy; Silicone oil implant

Mesh:

Substances:

Year:  2017        PMID: 28674834     DOI: 10.1007/s00417-017-3714-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

Review 1.  Mechanisms of intraocular inflammation.

Authors:  M T Magone; S M Whitcup
Journal:  Chem Immunol       Date:  1999

2.  Chronic prephthisical ocular hypotony treated by intravitreal triamcinolone acetonide.

Authors:  Jost B Jonas; Urs Vossmerbaeumer; Bernd A Kamppeter
Journal:  Acta Ophthalmol Scand       Date:  2004-10

Review 3.  Complications of emulsified silicone oil after retinal detachment repair.

Authors:  John B Miller; Thanos D Papakostas; Demetrios G Vavvas
Journal:  Semin Ophthalmol       Date:  2014 Sep-Nov       Impact factor: 1.975

4.  Ultrathin coatings from isocyanate-terminated star PEG prepolymers: layer formation and characterization.

Authors:  Juergen Groll; Thomas Ameringer; Joachim P Spatz; Martin Moeller
Journal:  Langmuir       Date:  2005-03-01       Impact factor: 3.882

5.  Kinetic and thermodynamic control of protein adsorption.

Authors:  J Satulovsky; M A Carignano; I Szleifer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

6.  The cross-linked biopolymer hyaluronic acid as an artificial vitreous substitute.

Authors:  Charlotte Schramm; Martin S Spitzer; Sigrid Henke-Fahle; Gabriele Steinmetz; Kai Januschowski; Peter Heiduschka; Jürgen Geis-Gerstorfer; Tilo Biedermann; Karl U Bartz-Schmidt; Peter Szurman
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-02       Impact factor: 4.799

7.  Surface-modified silicone foils for intraocular implantation.

Authors:  Sarah Fischer; Dörthe Carstesen; Doris Klee; Peter Walter; Andreas W A Weinberger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-02-23       Impact factor: 3.117

8.  Clinical fracture of cross-linked UHMWPE acetabular liners.

Authors:  Jevan Furmanski; Martin Anderson; Sonny Bal; A Seth Greenwald; David Halley; Brad Penenberg; Michael Ries; Lisa Pruitt
Journal:  Biomaterials       Date:  2009-07-29       Impact factor: 12.479

9.  Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection.

Authors:  Rashmi Kapur; Andrea D Birnbaum; Debra A Goldstein; Howard H Tessler; Michael J Shapiro; Lawrence J Ulanski; Michael P Blair
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

10.  The effects of 2% ibopamine eye drops on the intraocular pressure and pupil motility of patients with open-angle glaucoma.

Authors:  I Giuffrè; L Taverniti; S Di Staso
Journal:  Eur J Ophthalmol       Date:  2004 Nov-Dec       Impact factor: 1.922

View more
  1 in total

Review 1.  Advanced strategies to thwart foreign body response to implantable devices.

Authors:  Simone Capuani; Gulsah Malgir; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Bioeng Transl Med       Date:  2022-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.